Mapping a cardiomyopathy locus to chromosome 3p22-p25
1Division of Pediatric Cardiology, Primary Children's Medical Center, University of Utah Health Sciences Center, Salt Lake City 84112, USA.
The Journal of Clinical Investigation
|January 15, 1996
Summary
Researchers identified a novel dilated cardiomyopathy (DCM) gene linked to heart rhythm and conduction issues. This finding on chromosome 3p is a crucial step toward understanding DCM genetic causes.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is a prevalent heart condition marked by cardiac enlargement and impaired pumping function.
- DCM can be associated with complex arrhythmias, conduction problems, and an increased risk of stroke.
Purpose of the Study:
- To identify the specific gene responsible for a familial form of DCM presenting with cardiac dysfunction and rhythm abnormalities.
- To localize the genetic locus for this DCM subtype using linkage analysis.
Main Methods:
- A family with hereditary DCM and associated rhythm/conduction defects was studied.
- General linkage analysis and haplotype analysis were employed to map the disease gene.
- Exclusion of candidate genes within the mapped region was performed.
Main Results:
- Significant linkage was found to marker D3S2303 (lod score 6.09).
- Haplotype analysis localized the DCM-associated gene to a 30 cM region on chromosome 3p22-p25.
- Several candidate genes, including GNAI2, CACNL1A2, SCN5A, and ITPR1, were excluded.
Conclusions:
- A gene responsible for DCM with associated rhythm and conduction abnormalities is located on chromosome 3p.
- This study represents a significant advancement in the genetic investigation of DCM.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
01:17Karyotyping
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...